AstraZeneca updates coronavirus vaccine data after officials ‘expressed concern’ about ‘outdated’ info

Published



AstraZeneca released additional information regarding their latest COVID-19 vaccine trial after government officials expressed concern that they were using outdated information.

The newly released data, unveiled on Thursday, show a vaccine efficacy lower than the data previously released. After they released the data on Monday, which showed a 79% efficacy in preventing symptomatic cases, the National Institutes of Health’s committee of clinical trial analysts “expressed concern that AstraZeneca may have included outdated information from that trial.”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.